Expert Opinion on Drug Metabolism and Toxicology 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Predicting drug –drug interactions in breast cancer patients treated with CDK4/6 inhibitors and forward planning
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - April 23, 2024 Category: Drugs & Pharmacology Authors: Abha KulkarniJasmeet Singha Department of Medicine, New York Presbyterian Weill Cornell, New York, NY USAb Department of Breast Medicine, Memorial Sloan Kettering Cancer Center, West Harrison, NY USA Source Type: research
Optimizing co-prescription of clozapine and antiseizure medications: a systematic review and expert recommendations for clinical practice
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - April 18, 2024 Category: Drugs & Pharmacology Authors: H élène VerdouxClélia QuilesJose de Leona Univ. Bordeaux, Inserm, Bordeaux Population Health Research Center, team pharmacoepidemiology, Bordeaux, Franceb Centre Hospitalier Charles Perrens, Bordeaux, Francec Mental Health Research Center at Eastern St Source Type: research
Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes: an update
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - April 11, 2024 Category: Drugs & Pharmacology Authors: Brian TomlinsonPaul Chana Faculty of Medicine, Macau University of Science and Technology, Macau, Chinab Division of Cardiology, Department of Internal Medicine, Wan Fang Hospital, Taipei Medical University, Taipei City, Taiwan Source Type: research
Adverse events related to drug –drug interactions in COVID-19 patients. A persistent concern in the post-pandemic era: a systematic review
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - April 5, 2024 Category: Drugs & Pharmacology Authors: Valeria ContiNicola BertiniRosaria RicciardiBerenice StefanelliEmanuela De BellisCarmine SellittoMarco CascellaFrancesco SabbatinoGraziamaria CorbiPasquale PaglianoAmelia Filippellia Department of Medicine, Surgery, and Dentistry, University of Salerno, B Source Type: research
Bioactivity descriptors for in vivo toxicity prediction: now and the future
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - April 4, 2024 Category: Drugs & Pharmacology Authors: Palle HelmkeBarbara F üziGerhard F. EckerUniversity of Vienna, Department of Pharmaceutical Sciences, Josef-Holaubek Platz 2, Wien, Austria Source Type: research
Clinical pharmacokinetics and pharmacodynamics of topical non-biological therapies for psoriasis patients
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - April 2, 2024 Category: Drugs & Pharmacology Authors: Angela LoJonathan D. GreenzaidHannah Y. GantzKamran ChodriSteven R. Feldmana University of Central Florida College of Medicine, Orlando, FL, USAb Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USAc Department of P Source Type: research
Clinical pharmacokinetics and pharmacodynamics of oral systemic nonbiologic therapies for psoriasis patients
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 28, 2024 Category: Drugs & Pharmacology Authors: Justin M. EichingerDivya M. ShanJonathan D. GreenzaidLisa AnakwenzeSteven R. Feldmana University of Louisville School of Medicine, Louisville, KY, USAb Virginia Commonwealth University School of Medicine, Richmond, VA, USAc Department of Dermatology, Wake Source Type: research
Metabolic and toxicological considerations of Bruton ’s tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 25, 2024 Category: Drugs & Pharmacology Authors: Anna Wolska-WasherPawe ł RobakMagdalena WitkowskaTadeusz Robaka Department of Hematology, Medical University of Lodz, Lodz, Polandb Department of Hematooncology, Copernicus Memorial Hospital, Lodz, Polandc Department of General Hematology, Copernicus Mem Source Type: research
Predictive Modelling in pharmacokinetics: from in-silico simulations to personalized medicine
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 21, 2024 Category: Drugs & Pharmacology Authors: Ajita PaliwalSmita JainSachin KumarPranay WalMadhusmruti KhandaiPrasanna Shama KhandigeVandana SadanandaMd. Khalid AnwerMonica GulatiTapan BehlShriyansh Srivastavaa Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Great Source Type: research
Metabolism, toxicity and management of fruquintinib: a novel drug for metastatic colorectal cancer
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 20, 2024 Category: Drugs & Pharmacology Authors: Kanchi PatellVeronica Lee MearsMichael H. StorandtAmit Mahipala Hematology and Oncology Fellow, University Hospitals Seidman Cancer Center, Case Western Reserve University, Cleveland, OH, USAb GI Oncology Clinical Pharmacist Specialist, University Hospita Source Type: research
Risk factors associated with high-dose methotrexate induced toxicities
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 19, 2024 Category: Drugs & Pharmacology Authors: Wenshu LiJiayi MoZhilin YangZhigang ZhaoShenghui Meia Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing, P. R. Chinab Department of Clinical Pharmacology, College of Pharmaceutical Sciences, Capital Medical University, Source Type: research
A comprehensive update on the ADMET considerations for α2δ calcium channel ligand medications for treating restless legs syndrome
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 15, 2024 Category: Drugs & Pharmacology Authors: Gaia PellitteriSalvatore VersaceGiovanni MerlinoAnnacarmen NiloGian Luigi GigliMariarosaria Valentea Clinical Neurology Unit, Udine University Hospital, Udine, Italyb Department of Medicine (DMED), University of Udine, Udine, Italy Source Type: research
Beyond the hype and toward application: liver complex in vitro models in preclinical drug safety
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 13, 2024 Category: Drugs & Pharmacology Authors: Sushma JadalannagariLorna EwartDepartment of Bioinnovations, Emulate Inc, Boston, MA, USA Source Type: research
Cannabidiol: metabolism and clinical efficacy in epileptic patients
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 13, 2024 Category: Drugs & Pharmacology Authors: Giovanni Battista Dell ’isolaAlberto VerrottiMiriam SciaccalugaGianluca DiniPietro FerraraLucilla ParnettiCinzia Costaa Department of Pediatrics, University of Perugia, Perugia, Italyb Section of Neurology, Laboratory of Experimental Neurology, Departme Source Type: research
Drug interactions of carbonic anhydrase inhibitors and activators
. (Source: Expert Opinion on Drug Metabolism and Toxicology)
Source: Expert Opinion on Drug Metabolism and Toxicology - March 11, 2024 Category: Drugs & Pharmacology Authors: Claudiu T. SupuranNeurofarba Department, Pharmaceutical and Nutraceutical Section, University of Florence, Sesto Fiorentino, FI, Italy Source Type: research
